Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Western New York
356
mi
from 43215
Rochester, NY
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Western New York
356
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Cole Eye Institute - Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Cole Eye Institute - Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Oregon Retina
2055
mi
from 43215
Eugene, OR
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Oregon Retina
2055
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Pennsylvania Retina Specialists, P.C.
322
mi
from 43215
Camp Hill, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Pennsylvania Retina Specialists, P.C.
322
mi
from 43215
Camp Hill, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Mid Atlantic Retina- Wills Eye Institute
416
mi
from 43215
Philadelphia, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Mid Atlantic Retina- Wills Eye Institute
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Eye Center
165
mi
from 43215
Pittsburgh, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Eye Center
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Associates in Ophthalmology
165
mi
from 43215
West Mifflin, PA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Associates in Ophthalmology
165
mi
from 43215
West Mifflin, PA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Research Institute of Texas, LLC
1070
mi
from 43215
Abilene, TX
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Research Institute of Texas, LLC
1070
mi
from 43215
Abilene, TX
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Brian B. Berger, MD and Associates / Retina Research Center
1065
mi
from 43215
Austin, TX
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Brian B. Berger, MD and Associates / Retina Research Center
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
University of Virginia
275
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Wagner Macula and Retina Center
437
mi
from 43215
Virginia Beach, VA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Wagner Macula and Retina Center
437
mi
from 43215
Virginia Beach, VA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Macula and Retina Institute
1970
mi
from 43215
Glendale, CA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Macula and Retina Institute
1970
mi
from 43215
Glendale, CA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Consultants, San Diego
1938
mi
from 43215
Poway, CA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants, San Diego
1938
mi
from 43215
Poway, CA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Associates of Florida
842
mi
from 43215
Saint Petersburg, FL
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Associates of Florida
842
mi
from 43215
Saint Petersburg, FL
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Harvard Vanguard Medical Associates
643
mi
from 43215
Boston, MA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Harvard Vanguard Medical Associates
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Delaware Valley Retina Associates
438
mi
from 43215
Lawrenceville, NJ
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Delaware Valley Retina Associates
438
mi
from 43215
Lawrenceville, NJ
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retinal and Ophthalmic Consultants
452
mi
from 43215
Northfield, NJ
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal and Ophthalmic Consultants
452
mi
from 43215
Northfield, NJ
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
New York Eye & Ear
442
mi
from 43215
New York, NY
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
New York Eye & Ear
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of South Texas
1138
mi
from 43215
San Antonio, TX
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of South Texas
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Virginia Retina Center
292
mi
from 43215
Warrenton, VA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Virginia Retina Center
292
mi
from 43215
Warrenton, VA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Cosultants
133
mi
from 43215
Charleston, WV
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Cosultants
133
mi
from 43215
Charleston, WV
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
George Washington University
328
mi
from 43215
Washington,
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
George Washington University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Chicago Cornea Consultants, LTD
302
mi
from 43215
Hoffman Estates, IL
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Chicago Cornea Consultants, LTD
302
mi
from 43215
Hoffman Estates, IL
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Jackson Eye
312
mi
from 43215
Lake Villa, IL
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Jackson Eye
312
mi
from 43215
Lake Villa, IL
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Charles River Eye Associates
640
mi
from 43215
Winchester, MA
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Charles River Eye Associates
640
mi
from 43215
Winchester, MA
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Associated Eye Care
609
mi
from 43215
Stillwater, MN
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Associated Eye Care
609
mi
from 43215
Stillwater, MN
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Ophthalmology Consultants Ltd
408
mi
from 43215
Saint Louis, MO
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Ophthalmology Consultants Ltd
408
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
The May Eye Care Center
mi
from 43215
Hanover, PA
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
The May Eye Care Center
mi
from 43215
Hanover, PA
Click here to add this to my saved trials
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Carolina Eyecare Physicians, LLC
524
mi
from 43215
Mount Pleasant, SC
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Carolina Eyecare Physicians, LLC
524
mi
from 43215
Mount Pleasant, SC
Click here to add this to my saved trials
Study on Visual Function Impairments in Dry Age-related Macular Degeneration
Evaluation of Visual Function Impairments in Patients With Early Dry Age-related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Duke Eye Center
352
mi
from 43215
Durham, NC
Study on Visual Function Impairments in Dry Age-related Macular Degeneration
Evaluation of Visual Function Impairments in Patients With Early Dry Age-related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Duke Eye Center
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Northwestern University
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Oregon Health & Science University, Casey Eye Institute
2027
mi
from 43215
Portland, OR
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University, Casey Eye Institute
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Royal Victorian Eye and Ear Hospital
9882
mi
from 43215
Melbourne,
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Royal Victorian Eye and Ear Hospital
9882
mi
from 43215
Melbourne,
Click here to add this to my saved trials
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated:  12/31/1969
Francis I. Proctor Foundation
2109
mi
from 43215
San Francisco, CA
Methotrexate and Mycophenolate Mofetil for UVEITIS
First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial
Status: Enrolling
Updated: 12/31/1969
Francis I. Proctor Foundation
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Gevokizumab for Active Scleritis
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Gevokizumab for Active Scleritis
Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Nitisinone for Type 1B Oculocutaneous Albinism
A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Nitisinone for Type 1B Oculocutaneous Albinism
A Pilot Study of Nitisinone in the Treatment of Oculocutaneous Albinism, Type 1B
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD for Treatment of Ocular Inflammation Associated With Cataract Surgery
Status: Enrolling
Updated:  12/31/1969
Toyos Clinic
333
mi
from 43215
Nashville, TN
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD for Treatment of Ocular Inflammation Associated With Cataract Surgery
Status: Enrolling
Updated: 12/31/1969
Toyos Clinic
333
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Toric Eye Strain and Stability Study
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Toric Eye Strain and Stability Study
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Advanced Vision Care
1972
mi
from 43215
Los Angeles, CA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Advanced Vision Care
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Jules Stein Eye Institute
1972
mi
from 43215
Los Angeles, CA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Jules Stein Eye Institute
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Eye Consultants of Atlanta
436
mi
from 43215
Atlanta, GA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Eye Consultants of Atlanta
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Price Vision Group
167
mi
from 43215
Indianapolis, IN
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Price Vision Group
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Minnesota Eye Consultants
622
mi
from 43215
Bloomington, MN
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Minnesota Eye Consultants
622
mi
from 43215
Bloomington, MN
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
The Mackool Eye Institute
482
mi
from 43215
Astoria, NY
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
The Mackool Eye Institute
482
mi
from 43215
Astoria, NY
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Rosenthal Eye Surgery
mi
from 43215
Great Neck, NY
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Rosenthal Eye Surgery
mi
from 43215
Great Neck, NY
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Cincinnati Eye Institute
98
mi
from 43215
Cincinnati, OH
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Oregon Eye Associates
mi
from 43215
Eugene, OR
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Oregon Eye Associates
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Wills Eye Institute
416
mi
from 43215
Philadelphia, PA
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Wills Eye Institute
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
Alkek Eye Center/ Baylor College of Medicine
mi
from 43215
Houston, TX
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
Alkek Eye Center/ Baylor College of Medicine
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated:  12/31/1969
The Eye Institute of Utah
1513
mi
from 43215
Salt Lake City, UT
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
Status: Enrolling
Updated: 12/31/1969
The Eye Institute of Utah
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials